Search Results - V. A. Shuvaev

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Review of the 2nd day of the II Scientific and Practical Conference in a hybrid format “Achievements, problems and prospects in hematology”. Treatment and diagnosis of patients wit... by V. A. Shuvaev

    Published in Онкогематология (2023-12-01)
    Get full text
    Article


  2. 2

    How we treat polycythemia vera by V. A. Shuvaev, I. S. Martynkevich

    Published in Онкогематология (2024-01-01)
    Get full text
    Article


  3. 3

    All we know about polycythemia vera: literature review and own experience by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

    Published in Онкогематология (2015-10-01)
    Get full text
    Article


  4. 4

    Dasatinib: ten years of clinical practice worldwide by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

    Published in Онкогематология (2016-03-01)
    Get full text
    Article


  5. 5

    Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

    Published in Онкогематология (2015-06-01)
    Get full text
    Article


  6. 6

    Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

    Published in Онкогематология (2015-06-01)
    Get full text
    Article


  7. 7

    Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

    Published in Онкогематология (2015-01-01)
    Get full text
    Article


  8. 8

    Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

    Published in Онкогематология (2015-01-01)
    Get full text
    Article


  9. 9

    Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults by E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

    Get full text
    Article


  10. 10

    Clinical Case of Posterior Reversible Encephalopathy Syndrome in a Female Patient Undergoing Surgery for Rectal Cancer by M. M. Geraskinа, A. B. Galitsynа, V. A. Shuvaev, S. S. Gosteva

    Get full text
    Article


  11. 11

    Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma by S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

    Published in Онкогематология (2014-07-01)
    Get full text
    Article


  12. 12

    Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis by M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

    Published in Онкогематология (2016-08-01)
    Get full text
    Article


  13. 13

    Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

    Published in Онкогематология (2014-07-01)
    Get full text
    Article


  14. 14

    Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

    Published in Онкогематология (2014-07-01)
    Get full text
    Article


  15. 15

    Features of CLOCC syndrome in the patient b-lymphoblastic lymphoma. A case report by A. Yu. Terekhova, A. B. Galitsyna, A. M. Chelmakov, N. A. Falaleeva, V. A. Shuvaev, A. A. Danilenko, M. M. Geraskina, T. A. Agababyan, V. O. Ripp, D. A. Manaenkov, S. A. Ivanov

    Get full text
    Article


  16. 16

    Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia by D. V. Kustova, E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova, E. V. Morozova, E. G. Lomaia, V. A. Shuvaev, S. V. Sidorkevich, I. S. Martynkevich

    Published in Онкогематология (2024-09-01)
    Get full text
    Article


  17. 17

    THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA by A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

    Published in Онкогематология (2017-06-01)
    Get full text
    Article


  18. 18

    The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients by S. V. Voloshin, A. D. Garifullin, A. A. Kuzyaeva, N. N. Sinitsina, N. N. Alekseeva, A. V. Schmidt, S. Y. Linnikov, V. A. Shuvaev, A. Y. Kuvshinov, N. A. Potikhonova, A. V. Seltser, V. A. Balashova, Z. V. Chubukina, A. N. Bogdanov, S. V. Sidorkevich

    Published in Онкогематология (2022-04-01)
    Get full text
    Article


Search Tools: